Cargando…
Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma
BACKGROUND: Basan syndrome is a rare autosomal-dominant ectodermal dysplasia with certain clinic-pathological features caused by mutations in the SMARCAD1 gene. Currently, no skin malignancy related to Basan syndrome has been reported. This study was aimed at identifying related gene mutations in a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113868/ https://www.ncbi.nlm.nih.gov/pubmed/35592705 http://dx.doi.org/10.1155/2022/7840710 |
_version_ | 1784709655634640896 |
---|---|
author | Xiong, Ying Chen, Ting Yu, Jia Zhou, He Lu, Baozhen Chen, Lijie Sun, Liwei Wang, Can Li, Sujun Wu, Bo |
author_facet | Xiong, Ying Chen, Ting Yu, Jia Zhou, He Lu, Baozhen Chen, Lijie Sun, Liwei Wang, Can Li, Sujun Wu, Bo |
author_sort | Xiong, Ying |
collection | PubMed |
description | BACKGROUND: Basan syndrome is a rare autosomal-dominant ectodermal dysplasia with certain clinic-pathological features caused by mutations in the SMARCAD1 gene. Currently, no skin malignancy related to Basan syndrome has been reported. This study was aimed at identifying related gene mutations in a new Chinese pedigree with Basan syndrome and discovering the possible association between Basan syndrome and cutaneous squamous cell carcinoma (cSCC). METHODS: We report a case of Basan syndrome from China with family history of cSCC. The pedigree contains 28 individuals. Among them, 12 members had Basan syndrome, while 4 affected members were diagnosed with cSCC in the 1st and 2nd generations. Whole exome sequencing (WES) and Sanger sequencing were performed for 7 available individuals. The specific gene mutation on pre-mRNA splicing was also analyzed using in vitro Minigene assay. In addition, sequencing data was analyzed with bioinformatics workflow, aiming to discover the gene associated with cSCC. RESULTS: Gene sequencing results showed a heterozygous mutation, c.378+5G>A, in the SMARCAD1 gene in all tested individuals with Basan syndrome. Minigene result implicated the specific mutation may cause splicing variations by exon skipping occurring in the targeted exons. CONCLUSION: To the best of our knowledge, this is the first study reported Basan syndrome with family history of cSCC. Despite in this study we cannot draw any conclusion about the association between Basan syndrome and cSCC at the genetic level, this study encourages future works to substantiate this potential but important issue. |
format | Online Article Text |
id | pubmed-9113868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-91138682022-05-18 Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma Xiong, Ying Chen, Ting Yu, Jia Zhou, He Lu, Baozhen Chen, Lijie Sun, Liwei Wang, Can Li, Sujun Wu, Bo Dis Markers Research Article BACKGROUND: Basan syndrome is a rare autosomal-dominant ectodermal dysplasia with certain clinic-pathological features caused by mutations in the SMARCAD1 gene. Currently, no skin malignancy related to Basan syndrome has been reported. This study was aimed at identifying related gene mutations in a new Chinese pedigree with Basan syndrome and discovering the possible association between Basan syndrome and cutaneous squamous cell carcinoma (cSCC). METHODS: We report a case of Basan syndrome from China with family history of cSCC. The pedigree contains 28 individuals. Among them, 12 members had Basan syndrome, while 4 affected members were diagnosed with cSCC in the 1st and 2nd generations. Whole exome sequencing (WES) and Sanger sequencing were performed for 7 available individuals. The specific gene mutation on pre-mRNA splicing was also analyzed using in vitro Minigene assay. In addition, sequencing data was analyzed with bioinformatics workflow, aiming to discover the gene associated with cSCC. RESULTS: Gene sequencing results showed a heterozygous mutation, c.378+5G>A, in the SMARCAD1 gene in all tested individuals with Basan syndrome. Minigene result implicated the specific mutation may cause splicing variations by exon skipping occurring in the targeted exons. CONCLUSION: To the best of our knowledge, this is the first study reported Basan syndrome with family history of cSCC. Despite in this study we cannot draw any conclusion about the association between Basan syndrome and cSCC at the genetic level, this study encourages future works to substantiate this potential but important issue. Hindawi 2022-05-10 /pmc/articles/PMC9113868/ /pubmed/35592705 http://dx.doi.org/10.1155/2022/7840710 Text en Copyright © 2022 Ying Xiong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Xiong, Ying Chen, Ting Yu, Jia Zhou, He Lu, Baozhen Chen, Lijie Sun, Liwei Wang, Can Li, Sujun Wu, Bo Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma |
title | Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma |
title_full | Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma |
title_fullStr | Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma |
title_full_unstemmed | Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma |
title_short | Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma |
title_sort | association between mutation in smarcad1 and basan syndrome with cutaneous squamous cell carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113868/ https://www.ncbi.nlm.nih.gov/pubmed/35592705 http://dx.doi.org/10.1155/2022/7840710 |
work_keys_str_mv | AT xiongying associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma AT chenting associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma AT yujia associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma AT zhouhe associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma AT lubaozhen associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma AT chenlijie associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma AT sunliwei associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma AT wangcan associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma AT lisujun associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma AT wubo associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma |